First National Bank Of Mount Dora, Trust Investment Services Eli Lilly & CO Transaction History

First National Bank Of Mount Dora, Trust Investment Services

  • $423 Million
  • Q3 2024

A detailed history of First National Bank Of Mount Dora, Trust Investment Services transactions in Eli Lilly & CO stock. As of the latest transaction made, First National Bank Of Mount Dora, Trust Investment Services holds 10,073 shares of LLY stock, worth $8.01 Million. This represents 2.11% of its overall portfolio holdings.

Number of Shares
10,073
Previous 10,389 3.04%
Holding current value
$8.01 Million
Previous $9.41 Million 5.11%
% of portfolio
2.11%
Previous 2.36%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$772.14 - $960.02 $243,996 - $303,366
-316 Reduced 3.04%
10,073 $8.92 Million
Q2 2024

Jul 11, 2024
SELL
$724.87 - $909.04 $139,899 - $175,444
-193 Reduced 1.82%
10,389 $9.41 Million
Q1 2024

Apr 10, 2024
SELL
$592.2 - $792.28 $894,222 - $1.2 Million
-1,510 Reduced 12.49%
10,582 $8.23 Million
Q4 2023

Jan 05, 2024
SELL
$525.19 - $619.13 $419,626 - $494,684
-799 Reduced 6.2%
12,092 $7.05 Million
Q3 2023

Oct 10, 2023
SELL
$434.7 - $599.3 $490,341 - $676,010
-1,128 Reduced 8.05%
12,891 $6.92 Million
Q2 2023

Jul 07, 2023
SELL
$350.74 - $468.98 $1.41 Million - $1.88 Million
-4,011 Reduced 22.25%
14,019 $6.57 Million
Q1 2023

Apr 12, 2023
SELL
$310.63 - $364.82 $46,594 - $54,723
-150 Reduced 0.83%
18,030 $6.19 Million
Q4 2022

Jan 05, 2023
SELL
$321.55 - $374.67 $224,763 - $261,894
-699 Reduced 3.7%
18,180 $6.65 Million
Q3 2022

Oct 06, 2022
SELL
$296.48 - $337.87 $446,202 - $508,494
-1,505 Reduced 7.38%
18,879 $6.1 Million
Q2 2022

Jul 13, 2022
SELL
$278.73 - $327.27 $59,369 - $69,708
-213 Reduced 1.03%
20,384 $6.61 Million
Q1 2022

Apr 06, 2022
BUY
$234.69 - $291.66 $650,325 - $808,189
2,771 Added 15.54%
20,597 $5.9 Million
Q4 2021

Jan 10, 2022
BUY
$224.85 - $279.04 $33,277 - $41,297
148 Added 0.84%
17,826 $4.92 Million
Q3 2021

Oct 06, 2021
SELL
$221.6 - $272.71 $204,980 - $252,256
-925 Reduced 4.97%
17,678 $4.09 Million
Q2 2021

Jul 02, 2021
SELL
$180.55 - $233.54 $75,469 - $97,619
-418 Reduced 2.2%
18,603 $4.27 Million
Q1 2021

Apr 05, 2021
SELL
$164.32 - $212.72 $315,494 - $408,422
-1,920 Reduced 9.17%
19,021 $3.55 Million
Q4 2020

Jan 06, 2021
BUY
$130.46 - $172.63 $75,405 - $99,780
578 Added 2.84%
20,941 $3.54 Million
Q3 2020

Oct 08, 2020
SELL
$146.22 - $169.13 $23,980 - $27,737
-164 Reduced 0.8%
20,363 $3.01 Million
Q2 2020

Jul 08, 2020
SELL
$136.42 - $164.18 $1.31 Million - $1.58 Million
-9,598 Reduced 31.86%
20,527 $3.37 Million
Q1 2020

Apr 03, 2020
SELL
$119.05 - $147.35 $170,003 - $210,415
-1,428 Reduced 4.53%
30,125 $4.18 Million
Q4 2019

Jan 24, 2020
BUY
$106.92 - $132.43 $147,549 - $182,753
1,380 Added 4.57%
31,553 $4.15 Million
Q3 2019

Oct 09, 2019
BUY
$106.79 - $116.16 $2.55 Million - $2.77 Million
23,834 Added 375.99%
30,173 $3.37 Million
Q2 2019

Jul 08, 2019
SELL
$110.79 - $129.32 $31,575 - $36,856
-285 Reduced 4.3%
6,339 $703,000
Q1 2019

Apr 02, 2019
SELL
$111.31 - $131.02 $123,108 - $144,908
-1,106 Reduced 14.31%
6,624 $859,000
Q4 2018

Jan 03, 2019
SELL
$105.9 - $118.64 $57,186 - $64,065
-540 Reduced 6.53%
7,730 $895,000
Q3 2018

Oct 09, 2018
SELL
$85.86 - $107.31 $92,127 - $115,143
-1,073 Reduced 11.48%
8,270 $887,000
Q2 2018

Jul 13, 2018
SELL
$75.7 - $86.88 $47,312 - $54,300
-625 Reduced 6.27%
9,343 $797,000
Q1 2018

Apr 04, 2018
SELL
$74.21 - $87.6 $32,949 - $38,894
-444 Reduced 4.26%
9,968 $771,000
Q4 2017

Jan 08, 2018
SELL
$81.94 - $87.89 $54,490 - $58,446
-665 Reduced 6.0%
10,412 $879,000
Q3 2017

Oct 05, 2017
BUY
$77.07 - $85.54 $853,704 - $947,526
11,077
11,077 $948,000

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track First National Bank Of Mount Dora, Trust Investment Services Portfolio

Follow First National Bank Of Mount Dora, Trust Investment Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of Mount Dora, Trust Investment Services, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of Mount Dora, Trust Investment Services with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email